Ranibizumab and pegaptanib for the treatment of age-related macular degeneration

Technology appraisal guidance
Reference number: TA155
Published: 27 August 2008
Last updated: 20 May 2024

Macular degeneration (age-related) - pegaptanib and ranibizumab: Appraisal consultation document (Large print format) (December 2007)

Macular degeneration (age-related) - pegaptanib and ranibizumab: Appraisal consultation document (Large print format) (December 2007)

Macular degeneration (age-related) - pegaptanib and ranibizumab: Appraisal consultation document (Large print format) (December 2007)
13 December 2007
(104.39 Kb 30 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 30 March 2010